Class of Stock [Axis] Series A Preferred Stock [Member] Series A-2 Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Concentration Risk Benchmark [Axis] Revenue from Contract with Customer Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] No Customer [Member] One Customer [Member] Accounts Receivable [Member] Customer One [Member] Customer Two [Member] Intangible Asset, Finite-Lived, Class [Axis] Patents [Member] Intangible Asset, Indefinite-Lived, Class [Axis] Web Domain [Member] Trademarks [Member] Product and Service [Axis] Allergy Diagnostic Kit Sales [Member] Integrated Service Program [Member] Immunotherapy Treatment Sales [Member] Clinical Study Revenue [Member] Subscription Revenue [Member] Shipping and Handling [Member] Training And Other Revenue [Member] Software, In-Development, Internally Developed, and Purchased [Member] MedScience Research Group [Member] Short-Term Debt, Type [Axis] Convertible Notes Payable One [Member] Debt Instrument [Axis] Note One Shareholder [Member] Convertible Notes Payable [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Subscription Agreements [Member] Sale of Stock [Axis] Private Placement [Member] Series A-2 Preferred Stock [Member] Antidilutive Securities [Axis] Common Equivalent Shares [Member] Share-Based Payment Arrangement, Option [Member] Warrant [Member] Income Statements Location [Axis] Research and Development Expenses [Member] General and Administrative Expenses [Member] Award Type [Axis] Option One [Member] Option Two [Member] Options Held [Member] Warrant One [Member] Related and Nonrelated Parties [Axis] Related Party [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] Current Assets: Cash and cash equivalents Accounts receivable, net Inventory Prepaid expenses and other current assets Total current assets Non-current assets: Intangible assets, net Total assets Liabilities and Stockholders’ Equity (Deficit) Current Liabilities: Accounts payable Other current liabilities Due to related party Loans payable Convertible notes payable Total current liabilities Non-current Liabilities: Loans payable, non-current portion Total non-current liabilities Total liabilities Commitments and contingencies (Note 14) Stockholders’ Equity (Deficit): Preferred stock value Common stock, 900,000,000 shares authorized, $0.0001 par value; 15,032,788 shares issued and outstanding Additional paid-in capital Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Preferred stock, shares authorized Preferred stock, par value Preferred stock, shares issued Preferred stock, shares outstanding Common stock, shares authorized Common stock, par value Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Cost of revenue Gross profit Operating Expenses: General and administrative Sales and marketing Research and development Amortization Total Operating Expenses Net operating loss Other income (expense): Interest expense Loss before income taxes Provision on income taxes Net loss Basic net loss per share Diluted net loss per share Weighted average shares outstanding, basic Weighted average shares outstanding, diluted Balance Balance, shares Shares issued for services Shares issued for services, shares Conversion of notes payable Conversion of notes payable, shares Net loss Balance Balance, shares Statement of Cash Flows [Abstract] Operating activities Adjustments to reconcile net loss to net cash from operating activities: Allowance for doubtful accounts Amortization of intangible assets and capitalized software Shares issued for services Changes in net assets and liabilities: Accounts receivable Inventory Prepaid expenses and other current assets Accounts payable Other current liabilities Cash flows from operating activities Financing activities: Repayments of loan borrowings Cash flows from financing activities Net change in cash Cash and cash equivalents – beginning of year Cash and cash equivalents - end of period Supplemental disclosures of cash flow activity: Cash paid for interest Cash paid for taxes Supplemental noncash investing and financing activity: Debt and accrued interest converted to shares of common stock Organization, Consolidation and Presentation of Financial Statements [Abstract] The Company Going Concern Accounting Policies [Abstract] Basis of Presentation Credit Loss [Abstract] Accounts Receivable Intangible Asset, Goodwill and Other [Abstract] Capitalized Software and Intangible Assets Loans Payable Loans Payable Debt Disclosure [Abstract] Convertible Notes Payable Equity [Abstract] Preferred Stock and Private Placement Offering of Common Stock Earnings Per Share [Abstract] Income and (Loss) Per Common Share Share-Based Payment Arrangement [Abstract] Stock-based Compensation Related Party Transactions [Abstract] Related Party Transactions Income Tax Disclosure [Abstract] Income Taxes Segment Reporting [Abstract] Segment Information Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Use of Estimates Principles of Consolidation Cash and Cash Equivalents Accounts Receivable Inventories Capitalized Software Development Costs Intangible Assets Convertible Notes Payable Revenue Recognition Research and Development Stock-based Compensation Earnings Per Common Share Income Taxes Recently Issued Accounting Standards Schedule of Indefinite-Lived Intangible Assets Schedule of Revenue Recognition Schedule of Accounts Receivable Schedule of Intangible Assets Schedule of Convertible Notes Payable Schedule of Anti-dilutive Securities Excluded from Calculation of Earnings Per Share Schedule of Options Outstanding and Exercisable Schedule of Warrants Outstanding and Exercisable Schedule of Effective Income Tax Reconciliation Accumulated deficit Net loss (income) Gain on extinguishment of debt Cash in operating activities Intangible Asset, Finite-Lived [Table] Intangible Asset, Finite-Lived [Line Items] Finite-lived intangible assets, amortization method Impaired intangible asset Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Total Revenue Concentration risk percentage Research and development expense Conversion of preferred shares Operating loss carryforwards Net operating losses carryforwards, expire date Accounts receivable Allowance for doubtful accounts Accounts receivable, net Capitalized software Accumulated amortization Capitalized software, net Intangible Assets: Total Intangible assets Accumulated amortization Intangible assets, net Amortization expense Impairments recognized Acquired intangible assets Amortization of intangible assets Impairment of intangible assets Proceeds from loan Payments for loan Loans current and non-current Loan payable Short-Term Debt [Table] Short-Term Debt [Line Items] Convertible notes payable gross Less: current portion Non-current portion Debt instrument face amount Interest rate Debt instrument, maturity date Debt instrument, description Outstanding amount Debt conversion amount Debt conversion price Debt conversion shares issued Conversion amount Interest payable, current Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary, Sale of Stock [Line Items] Common stock and warrants in a private placement offering Common stock and warrants in a private placement offering Purchase price, per share Warrants to purchase shares of common stock Warrants exercise price, per share Warrants expires date Preferred stock stated value Debt instrument convertible conversion price per share Preferred stock stated value Number of shares convertible into common stock price per share Preferred stock, cumulative dividend annual rate, percentage Common stock dividends shares Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Stock based compensation Common stock for services Share issued for services in general and administrative expense Options granted Options exercised, forfeited or cancelled Options expired Date Issued Number Outstanding Number Exercisable Exercise Price Expiration Date Date Issued Number Outstanding Number Exercisable Exercise Price Related Party Transaction [Table] Related Party Transaction [Line Items] Debt instrument, interest rate Non-current liabilities Loan and accrued interest Income tax at federal statutory rate Valuation allowance Income tax expense Deferred tax assets, valuation allowance Change in valuation allowance decrease Operating losses carryforward Operating losses carryforward expiration date description Series A-2 Preferred Stock [Member] Debt and accrued interest converted to shares of common stock. Web Domain [Member] Net operating losses carryforwards expire date. Customer One [Member] No Customer [Member] One Customer [Member] Convertible notes payable, gross. Convertible Notes Payable One [Member] Note One Shareholder [Member] Subscription Agreements [Member] MedScience Research Group [Member] Loans Payable [Text Block] Series A-2 Preferred Stock [Member] Common Equivalent Shares [Member] Income Statements Location [Axis] Research and Development Expenses [Member] General and Administrative Expenses [Member] Share based compensation arrangement by share based payment award option issuance date. Option One [Member] Option Two [Member] Share based compensation arrangement by share based payment award warrants issuance date. Warrant One [Member] Share based compensation arrangement by share based payment award warrants exercisable number. Share based compensation arrangement by share based payment award warrants outstanding weighted average exercise price. Series A-2 Preferred Stock [Member] [Default Label] Assets, Current Assets Liabilities, Current Liabilities, Noncurrent Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense, Operating and Nonoperating Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding Issuance of Stock and Warrants for Services or Claims Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Other Current Liabilities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Repayments of Short-Term Debt Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation LoansPayableTextBlock Receivable [Policy Text Block] Debt, Policy [Policy Text Block] Share-Based Payment Arrangement [Policy Text Block] Income Tax, Policy [Policy Text Block] Accounts Receivable, Allowance for Credit Loss, Current Capitalized Cost, Software to be Sold, Leased, or Marketed, Accumulated Amortization Capitalized Cost, Software to be Sold, Leased, or Marketed, after Accumulated Amortization Intangible Asset, Finite-Lived, Accumulated Amortization Stock Issued During Period, Shares, New Issues ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice Effective Income Tax Rate Reconciliation, Percent